The DOI matches its Crossref record; 332 of the 332 references it cites were found in a registry or an index.
Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review
Open accessAbstract
The absorption of oral drugs is frequently plagued by significant variability with potentially serious therapeutic consequences. The source of variability can be traced back to interindividual variability in physiology, differences in special populations (age- and disease-dependent), drug and formulation properties, or food-drug interactions. Clinical evidence for the impact of some of these factors on drug pharmacokinetic variability is mounting: e.g. gastric pH and emptying time, small intestinal fluid properties, differences in pediatrics and the elderly, and surgical changes in gastrointestinal anatomy. However, the link of colonic factors variability (transit time, fluid composition, microbiome), sex differences (male vs. female) and gut-related diseases (chronic constipation, anorexia and cachexia) to drug absorption variability has not been firmly established yet. At the same time, a way to decrease oral drug pharmacokinetic variability is provided by the pharmaceutical industry: clinical evidence suggests that formulation approaches employed during drug development can decrease the variability in oral exposure. This review outlines the main drivers of oral drug exposure variability and potential approaches to overcome them, while highlighting existing knowledge gaps and guiding future studies in this area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726 · cited 1×
“bacteria inhibiting the GIT at the genomic level (Huttenhower et al., 2012).”
BackgroundExtensive impact of non-antibiotic drugs on human gut bacteria
Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E. E., Brochado, A. R., Fernandez, K. C., Dose, H., Mori, H., et al. (2018) · Nature · doi:10.1038/nature25979 · Cited by 1,905 · cited 1×
“Age, diet, medication use, and lifestyle are all important determinants of an individual’s microbiome (Asnicar et al., 2021; Chaudhari et al., 2020; Keohane et al., 2020; Maier et al., 2018).”
BackgroundStrategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Self-citationProton pump inhibitors affect the gut microbiome
Imhann, F., Bonder, M. J., Vich Vila, A., Fu, J., Mujagic, Z., Vork, L., Tigchelaar, E. F., Jankipersadsing, S. A., Cenit, M. C., Harmsen, H. J. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310376 · Cited by 1,371 · cited 1×
“24 duodenum grows dramatically (Fisher and Fisher, 2017), and persistent changes toward a less healthy gut microbiome are observed in PPI users (Imhann et al., 2016) (for more information on the role of the gut microbiome in drug PK, see the relevant section in this manuscript).”
BackgroundMapping human microbiome drug metabolism by gut bacteria and their genes
Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R., & Goodman, A. L. (2019) · Nature · doi:10.1038/s41586-019-1291-3 · Cited by 1,160
Asnicar, F., Berry, S. E., Valdes, A. M., Nguyen, L. H., Piccinno, G., Drew, D. A., Leeming, E., Gibson, R., Le Roy, C., Khatib, H. A., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-01183-8 · Cited by 995
American Gastroenterological Association Technical Review on Constipation
Bharucha, A. E., Pemberton, J. H., & Locke, G. R. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.028 · Cited by 909
Transit of pharmaceutical dosage forms through the small intestine.
Davis, S. S., Hardy, J. G., & Fara, J. W. (1986) · Gut · doi:10.1136/gut.27.8.886 · Cited by 853
Clinical Pharmacokinetics of Mycophenolate Mofetil
Bullingham, R. E. S., Nicholls, A. J., & Kamm, B. R. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834060-00002 · Cited by 839
(2001) · Drugs and the Pharmaceutical Sciences · doi:10.1201/9780824741969.axh · Cited by 818
Upper Gastrointestinal (GI) pH in Young, Healthy Men and Women
Dressman, J. B., Berardi, R. R., Dermentzoglou, L. C., Russell, T. L., Schmaltz, S. P., Barnett, J. L., & Jarvenpaa, K. M. (1990) · Pharmaceutical Research · doi:10.1023/a:1015827908309 · Cited by 775
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
Maini Rekdal, V., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J., & Balskus, E. P. (2019) · Science · doi:10.1126/science.aau6323 · Cited by 753
Negative Effects of a High-Fat Diet on Intestinal Permeability: A Review
Rohr, M. W., Narasimhulu, C. A., Rudeski-Rohr, T. A., & Parthasarathy, S. (2020) · Advances in Nutrition · doi:10.1093/advances/nmz061 · Cited by 751
ESPEN guidelines on chronic intestinal failure in adults
Pironi, L., Arends, J., Bozzetti, F., Cuerda, C., Gillanders, L., Jeppesen, P. B., Joly, F., Kelly, D., Lal, S., Staun, M., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.01.020 · Cited by 722
Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta
Haiser, H. J., Gootenberg, D. B., Chatman, K., Sirasani, G., Balskus, E. P., & Turnbaugh, P. J. (2013) · Science · doi:10.1126/science.1235872 · Cited by 704
ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults
Pironi, L., Arends, J., Baxter, J., Bozzetti, F., Peláez, R. B., Cuerda, C., Forbes, A., Gabe, S., Gillanders, L., Holst, M., et al. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2014.08.017 · Cited by 688
Enterohepatic Circulation: Physiological, Pharmacokinetic and Clinical Implications
Roberts, M. S., Magnusson, B. M., Burczynski, F. J., & Weiss, M. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241100-00005 · Cited by 664
Kalantzi, L., Goumas, K., Kalioras, V., Abrahamsson, B., Dressman, J. B., & Reppas, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-8476-1 · Cited by 658
Self-citationGut microbiome interactions with drug metabolism, efficacy, and toxicity
Wilson, I. D., & Nicholson, J. K. (2017) · Translational Research · doi:10.1016/j.trsl.2016.08.002 · Cited by 656
From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
Self-citationMessing, B., Crenn, P., Beau, P., Boutron-Ruault, M. C., Rambaud, J.-C., & Matuchansky, C. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70388-4 · Cited by 632
The gastrointestinal microbiota as a site for the biotransformation of drugs
Sousa, T., Paterson, R., Moore, V., Carlsson, A., Abrahamsson, B., & Basit, A. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.009 · Cited by 618
Self-citationIntestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging
SCHILLER, C., FRÖHLICH, C. ‐., GIESSMANN, T., SIEGMUND, W., MÖNNIKES, H., HOSTEN, N., & WEITSCHIES, W. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02683.x · Cited by 596
Self-citationHuman pancreatic exocrine response to nutrients in health and disease
Keller, J., & Layer, P. (2005) · Gut · doi:10.1136/gut.2005.065946 · Cited by 551
van Kessel, S. P., Frye, A. K., El-Gendy, A. O., Castejon, M., Keshavarzian, A., van Dijk, G., & El Aidy, S. (2019) · Nature Communications · doi:10.1038/s41467-019-08294-y · Cited by 521
Bariatric surgery for obesity and metabolic disorders: state of the art
Nguyen, N. T., & Varela, J. E. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.170 · Cited by 505
Adlercreutz, H., Höckerstedt, K., Bannwart, C., Bloigu, S., Hämäläinen, E., Fotsis, T., & Ollus, A. (1987) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(87)90200-7 · Cited by 503
Identifying personal microbiomes using metagenomic codes
Franzosa, E. A., Huang, K., Meadow, J. F., Gevers, D., Lemon, K. P., Bohannan, B. J. M., & Huttenhower, C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423854112 · Cited by 497
Mudie, D. M., Murray, K., Hoad, C. L., Pritchard, S. E., Garnett, M. C., Amidon, G. L., Gowland, P. A., Spiller, R. C., Amidon, G. E., & Marciani, L. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500210c · Cited by 486
Ezetimibe: A Review of its Metabolism, Pharmacokinetics and Drug Interactions
Kosoglou, T., Statkevich, P., Johnson-Levonas, A. O., Paolini, J. F., Bergman, A. J., & Alton, K. B. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544050-00002 · Cited by 476
Personalized Mapping of Drug Metabolism by the Human Gut Microbiome
Javdan, B., Lopez, J. G., Chankhamjon, P., Lee, Y.-C. J., Hull, R., Wu, Q., Wang, X., Chatterjee, S., & Donia, M. S. (2020) · Cell · doi:10.1016/j.cell.2020.05.001 · Cited by 474
Koziolek, M., Grimm, M., Becker, D., Iordanov, V., Zou, H., Shimizu, J., Wanke, C., Garbacz, G., & Weitschies, W. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24274 · Cited by 464
Self-citationColonic transit time is related to bacterial metabolism and mucosal turnover in the gut
Roager, H. M., Hansen, L. B. S., Bahl, M. I., Frandsen, H. L., Carvalho, V., Gøbel, R. J., Dalgaard, M. D., Plichta, D. R., Sparholt, M. H., Vestergaard, H., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.93 · Cited by 449
Separating host and microbiome contributions to drug pharmacokinetics and toxicity
Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R., & Goodman, A. L. (2019) · Science · doi:10.1126/science.aat9931 · Cited by 423
Camilleri, M., Ford, A. C., Mawe, G. M., Dinning, P. G., Rao, S. S., Chey, W. D., Simrén, M., Lembo, A., Young-Fadok, T. M., & Chang, L. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.95 · Cited by 411
Developmental Changes in Pharmacokinetics and Pharmacodynamics
van den Anker, J., Reed, M. D., Allegaert, K., & Kearns, G. L. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1284 · Cited by 389
Self-citationThe mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
Koziolek, M., Alcaro, S., Augustijns, P., Basit, A. W., Grimm, M., Hens, B., Hoad, C. L., Jedamzik, P., Madla, C. M., Maliepaard, M., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.003 · Cited by 385
Self-citationDeciphering functional redundancy in the human microbiome
Tian, L., Wang, X.-W., Wu, A.-K., Fan, Y., Friedman, J., Dahlin, A., Waldor, M. K., Weinstock, G. M., Weiss, S. T., & Liu, Y.-Y. (2020) · Nature Communications · doi:10.1038/s41467-020-19940-1 · Cited by 380
Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine
Ahmed, S., Zhou, Z., Zhou, J., & Chen, S.-Q. (2016) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.03.008 · Cited by 371
Upper Gastrointestinal pH in Seventy-Nine Healthy, Elderly, North American Men and Women
Russell, T. L., Berardi, R. R., Barnett, J. L., Dermentzoglou, L. C., Jarvenpaa, K. M., Schmaltz, S. P., & Dressman, J. B. (1993) · Pharmaceutical Research · doi:10.1023/a:1018970323716 · Cited by 367
Boyd, B. J., Bergström, C. A. S., Vinarov, Z., Kuentz, M., Brouwers, J., Augustijns, P., Brandl, M., Bernkop-Schnürch, A., Shrestha, N., Préat, V., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.104967 · Cited by 367
Self-citationJakobsen, G. S., Småstuen, M. C., Sandbu, R., Nordstrand, N., Hofsø, D., Lindberg, M., Hertel, J. K., & Hjelmesæth, J. (2018) · JAMA · doi:10.1001/jama.2017.21055 · Cited by 358
Neuroimmune mechanisms in postoperative ileus
Boeckxstaens, G. E., & de Jonge, W. J. (2009) · Gut · doi:10.1136/gut.2008.169250 · Cited by 356
The gut microbiome: an orchestrator of xenobiotic metabolism
Collins, S. L., & Patterson, A. D. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.001 · Cited by 348
Sex Differences in Drug Disposition
Soldin, O. P., Chung, S. H., & Mattison, D. R. (2011) · BioMed Research International · doi:10.1155/2011/187103 · Cited by 341
Takasuna, K., Hagiwara, T., Hirohashi, M., Kato, M., Nomura, M., Nagai, E., Yokoi, T., & Kamataki, T. (1996) · PubMed · Cited by 336
Intestinal epithelial barrier function and tight junction proteins with heat and exercise
Dokladny, K., Zuhl, M. N., & Moseley, P. L. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00536.2015 · Cited by 326
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Stillhart, C., Vučićević, K., Augustijns, P., Basit, A. W., Batchelor, H., Flanagan, T. R., Gesquiere, I., Greupink, R., Keszthelyi, D., Koskinen, M., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105280 · Cited by 320
Self-citationGut reactions: Breaking down xenobiotic–microbiome interactions
Clarke, G., Sandhu, K. V., Griffin, B. T., Dinan, T. G., Cryan, J. F., & Hyland, N. P. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.015768 · Cited by 319 · cited 1×
“14 only emerged recently (Figure 10)(Clarke et al., 2019; Collins and Patterson, 2020; Scheline, 1968; Tian et al., 2020).”
BackgroundSelf-citationGender differences in the effects of cardiovascular drugs
Tamargo, J., Rosano, G., Walther, T., Duarte, J., Niessner, A., Kaski, J., Ceconi, C., Drexel, H., Kjeldsen, K., Savarese, G., et al. (2017) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvw042 · Cited by 317
ABC of palliative care: Anorexia, cachexia, and nutrition
Bruera, E. (1997) · BMJ · doi:10.1136/bmj.315.7117.1219 · Cited by 311
Absorption Enhancers: Applications and Advances
Aungst, B. J. (2012) · The AAPS Journal · doi:10.1208/s12248-011-9307-4 · Cited by 309
Overview on gastroretentive drug delivery systems for improving drug bioavailability
Lopes, C. M., Bettencourt, C., Rossi, A., Buttini, F., & Barata, P. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.05.016 · Cited by 305
Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles
Pavlović, N., Goločorbin-Kon, S., Ðanić, M., Stanimirov, B., Al-Salami, H., Stankov, K., & Mikov, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01283 · Cited by 305
Influence of gender and menopause on gastric emptying and motility
Hutson, W. R., Roehrkasse, R. L., & Wald, A. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90758-0 · Cited by 304
Distinct microbial and immune niches of the human colon
James, K. R., Gomes, T., Elmentaite, R., Kumar, N., Gulliver, E. L., King, H. W., Stares, M. D., Bareham, B. R., Ferdinand, J. R., Petrova, V. N., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0602-z · Cited by 294
Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery
Benet, L. Z., Izumi, T., Zhang, Y., Silverman, J. A., & Wacher, V. J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00034-6 · Cited by 292
Caliph, S. M., Charman, W. N., & Porter, C. J. H. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200008)89:8<1073::aid-jps12>3.0.co;2-v · Cited by 292
The influence of gut microbiota on drug metabolism and toxicity
Li, H., He, J., & Jia, W. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2016.1121234 · Cited by 278
Bile acids as metabolic regulators
Li, T., & Chiang, J. Y. L. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000156 · Cited by 269
Persson, E. M., Gustafsson, A.-S., Carlsson, A. S., Nilsson, R. G., Knutson, L., Forsell, P., Hanisch, G., Lennernäs, H., & Abrahamsson, B. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8192-x · Cited by 266
Intestinal Adaptation Following Resection
Tappenden, K. A. (2014) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607114525210 · Cited by 261
Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum
Armand, M., Borel, P., Pasquier, B., Dubois, C., Senft, M., Andre, M., Peyrot, J., Salducci, J., & Lairon, D. (1996) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1996.271.1.g172 · Cited by 259
Digoxin-Inactivating Bacteria: Identification in Human Gut Flora
Dobkin, J. F., Saha, J. R., Butler, V. P., Neu, H. C., & Lindenbaum, J. (1983) · Science · doi:10.1126/science.6836275 · Cited by 259
Drozdzik, M., Gröer, C., Penski, J., Lapczuk, J., Ostrowski, M., Lai, Y., Prasad, B., Unadkat, J. D., Siegmund, W., & Oswald, S. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500330y · Cited by 258
Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs
Bergström, C. A. S., Holm, R., Jørgensen, S. A., Andersson, S. B. E., Artursson, P., Beato, S., Borde, A., Box, K., Brewster, M., Dressman, J., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.10.015 · Cited by 257
Intestinal Microbiota Regulate Xenobiotic Metabolism in the Liver
Björkholm, B., Bok, C. M., Lundin, A., Rafter, J., Hibberd, M. L., & Pettersson, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006958 · Cited by 249 · cited 1×
“There, they can alter the hepatic transcriptome and thus the expression of CYP450 enzymes or drug transporters (Bjorkholm et al., 2009; Ishii et al., 2012; Kuno et al., 2016).”
BackgroundCharacterization of Human Duodenal Fluids in Fasted and Fed State Conditions
Riethorst, D., Mols, R., Duchateau, G., Tack, J., Brouwers, J., & Augustijns, P. (2016) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24603 · Cited by 245
Self-citationCamilleri, M., McKinzie, S., Busciglio, I., Low, P. A., Sweetser, S., Burton, D., Baxter, K., Ryks, M., & Zinsmeister, A. R. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.060 · Cited by 244
Pasipanodya, J. G., Srivastava, S., & Gumbo, T. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis353 · Cited by 239
Lacteal junction zippering protects against diet-induced obesity
Zhang, F., Zarkada, G., Han, J., Li, J., Dubrac, A., Ola, R., Genet, G., Boyé, K., Michon, P., Künzel, S. E., et al. (2018) · Science · doi:10.1126/science.aap9331 · Cited by 237
Vertzoni, M., Augustijns, P., Grimm, M., Koziolek, M., Lemmens, G., Parrott, N., Pentafragka, C., Reppas, C., Rubbens, J., Van Den Αbeele, J., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.013 · Cited by 224
Self-citationFink, M. P. (2003) · Current Opinion in Critical Care · doi:10.1097/00075198-200304000-00011 · Cited by 222
Proton pump inhibitors: Risks of long‐term use
Eusebi, L. H., Rabitti, S., Artesiani, M. L., Gelli, D., Montagnani, M., Zagari, R. M., & Bazzoli, F. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13737 · Cited by 219
Marciani, L., Cox, E. F., Hoad, C. L., Pritchard, S., Totman, J. J., Foley, S., Mistry, A., Evans, S., Gowland, P. A., & Spiller, R. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.055 · Cited by 218
Estimating the Maximal Potential for Intestinal Lymphatic Transport of Lipophilic Drug Molecules
Charman, W. N. A., & Stella, V. J. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90027-x · Cited by 217 · cited 1×
“This has been suggested to result from the ~500 fold higher flow rate of blood compared with lymph flow from the intestine (Charman and Stella, 1986).”
BackgroundPharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors
Blume, H., Donath, F., Warnke, A., & Schug, B. S. (2006) · Drug Safety · doi:10.2165/00002018-200629090-00002 · Cited by 216
Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis
Bolognesi, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2555 · Cited by 216
Effect of age on gastric emptying of liquid-solid meals in man
Moore, J. G., Tweedy, C., Christian, P. E., & Datz, F. L. (1983) · Digestive Diseases and Sciences · doi:10.1007/bf01324951 · Cited by 216
Age-associated modifications of intestinal permeability and innate immunity in human small intestine
Man, A. L., Bertelli, E., Rentini, S., Regoli, M., Briars, G., Marini, M., Watson, A. J. M., & Nicoletti, C. (2015) · Clinical Science · doi:10.1042/cs20150046 · Cited by 215
VEGF ‐C is required for intestinal lymphatic vessel maintenance and lipid absorption
Nurmi, H., Saharinen, P., Zarkada, G., Zheng, W., Robciuc, M. R., & Alitalo, K. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505731 · Cited by 211
Psachoulias, D., Vertzoni, M., Goumas, K., Kalioras, V., Beato, S., Butler, J., & Reppas, C. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0506-6 · Cited by 205
Self-citationHatton, G. B., Yadav, V., Basit, A. W., & Merchant, H. A. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24365 · Cited by 204 · cited 1×
“pH and volumes, GET and SITT, competition and/or regulation of intestinal transporters and drug metabolising enzymes, and the potential interactions of sex steroids on drug PK (Hatton et al., 2015) (Figure 13).”
BackgroundSelf-citationThe Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome.
Enright, E. F., Gahan, C. G. M., Joyce, S. A., & Griffin, B. T. (2016) · PubMed · Cited by 202
Self-citationIntestinal Transport During Fasting and Malnutrition
Ferraris, R. P., & Carey, H. V. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.195 · Cited by 201
Augustijns, P., Wuyts, B., Hens, B., Annaert, P., Butler, J., & Brouwers, J. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.027 · Cited by 199
Self-citationIbekwe, V. C., Fadda, H. M., McConnell, E. L., Khela, M. K., Evans, D. F., & Basit, A. W. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9580-9 · Cited by 199
Self-citationNew insights into the regulation of chylomicron production
Dash, S., Xiao, C., Morgantini, C., & Lewis, G. F. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034338 · Cited by 194 · cited 2×
“modulate lymphatic lipid transport including pancreatic lipase inhibitors, glucagon like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and modulators of lipoprotein metabolism such as fibrates and cholesterylester transfer protein (CETP) inhibitors (Dash et al., 2015; Trevaskis et al., 2010; Xiao et al., 2012…”
BackgroundSmelick, G. S., Heffron, T. P., Chu, L., Dean, B., West, D. A., DuVall, S. L., Lum, B. L., Budha, N., Holden, S. N., Benet, L. Z., et al. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400403s · Cited by 190
Does sex matter? The influence of gender on gastrointestinal physiology and drug delivery
Freire, A. C., Basit, A. W., Choudhary, R., Piong, C. W., & Merchant, H. A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.069 · Cited by 190
Self-citationGastroparesis and Parkinson’s disease: a systematic review
Heetun, Z. S., & Quigley, E. M. M. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.12.004 · Cited by 182
Hellriegel, E. T., Bjornsson, T. D., & Hauck, W. W. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90208-8 · Cited by 181
Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum
Moreno, M. P. D. L. C., Oth, M., Deferme, S., Lammert, F., Tack, J., Dressman, J., & Augustijns, P. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.8.0009 · Cited by 180
Self-citationMcbain, A. J., & Macfarlane, G. T. (1998) · Journal of Medical Microbiology · doi:10.1099/00222615-47-5-407 · Cited by 179
Drug-Drug Interaction Profiles of Proton Pump Inhibitors
Ogawa, R., & Echizen, H. (2010) · Clinical Pharmacokinetics · doi:10.2165/11531320-000000000-00000 · Cited by 179
Koziolek, M., Schneider, F., Grimm, M., Modeβ, C., Seekamp, A., Roustom, T., Siegmund, W., & Weitschies, W. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.022 · Cited by 176
Self-citationWANG, Y., TONG, J., CHANG, B., WANG, B., ZHANG, D., & WANG, B. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2126 · Cited by 175
Drug Metabolism by Intestinal Microorganisms
Scheline, R. R. (1968) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600571202 · Cited by 173
Ontogeny of Human Hepatic and Intestinal Transporter Gene Expression during Childhood: Age Matters
Mooij, M. G., Schwarz, U. I., de Koning, B. A. E., Leeder, J. S., Gaedigk, R., Samsom, J. N., Spaans, E., van Goudoever, J. B., Tibboel, D., Kim, R. B., et al. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.056929 · Cited by 173
Okuda, H., Ogura, K., Kato, A., Takubo, H., & Watabe, T. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37858-9 · Cited by 172
Gut dysfunction in Parkinson's disease
Mukherjee, A., Biswas, A., & Das, S. K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i25.5742 · Cited by 172
Koziolek, M., Grimm, M., Schneider, F., Jedamzik, P., Sager, M., Kühn, J.-P., Siegmund, W., & Weitschies, W. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.009 · Cited by 170
Self-citationFloch, M. H. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181b64b0c · Cited by 168
Delayed gastric emptying in Parkinson's disease
Marrinan, S. L., Emmanuel, A. V., & Burn, D. J. (2013) · Movement Disorders · doi:10.1002/mds.25708 · Cited by 167
Xiao, C., Bandsma, R. H. J., Dash, S., Szeto, L., & Lewis, G. F. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.246207 · Cited by 164
Polyphenols and Intestinal Permeability: Rationale and Future Perspectives
Bernardi, S., Del Bo’, C., Marino, M., Gargari, G., Cherubini, A., Andrés-Lacueva, C., Hidalgo-Liberona, N., Peron, G., González-Dominguez, R., Kroon, P., et al. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b02283 · Cited by 164
Mesenteric, coeliac and splanchnic blood flow in humans during exercise
Perko, M. J., Nielsen, H. B., Skak, C., Clemmesen, J. O., Schroeder, T. V., & Secher, N. H. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.907ba.x · Cited by 162
IS p-AMINOBENZENESULPHONAMIDE THE ACTIVE AGENT IN PRONTOSIL THERAPY ?
Fuller, A. T. (1937) · The Lancet · doi:10.1016/s0140-6736(00)97447-6 · Cited by 162
Corsetti, M., Costa, M., Bassotti, G., Bharucha, A. E., Borrelli, O., Dinning, P., Di Lorenzo, C., Huizinga, J. D., Jimenez, M., Rao, S., et al. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0167-1 · Cited by 160
Self-citationBonner, J. J., Vajjah, P., Abduljalil, K., Jamei, M., Rostami‐Hodjegan, A., Tucker, G. T., & Johnson, T. N. (2015) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1937 · Cited by 159
Mayeur, C., Gratadoux, J., Bridonneau, C., Chegdani, F., Larroque, B., Kapel, N., Corcos, O., Thomas, M., & Joly, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054335 · Cited by 159
LOCALIZATION AND mRNA EXPRESSION OF CYP3A AND P-GLYCOPROTEIN IN HUMAN DUODENUM AS A FUNCTION OF AGE
Fakhoury, M., Litalien, C., Médard, Y., Cavé, H., Ezzahir, N., Peuchmaur, M. M., & Jacqz-Aigrain, É. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005611 · Cited by 155
Kleberg, K., Jacobsen, J. B., & Müllertz, A. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01023.x · Cited by 154
Guo, S., Gillingham, T. Z., Guo, Y., Meng, D., Zhu, W., Walker, W. A., & Ganguli, K. A. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001310 · Cited by 154
Tannergren, C., Bergendal, A., Lennernäs, H., & Abrahamsson, B. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800261a · Cited by 153
Weitschies, W., Kosch, O., Mönnikes, H., & Trahms, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.01.025 · Cited by 153
Self-citationClarysse, S., Tack, J. F., Lammert, F., Duchateau, G. S. M. J. E., Reppas, C. I., & Augustijns, P. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21502 · Cited by 153
Self-citationPaediatric oral biopharmaceutics: Key considerations and current challenges
Batchelor, H. K., Fotaki, N., & Klein, S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.10.006 · Cited by 152
Farkouh, A., Riedl, T., Gottardi, R., Czejka, M. J., & Kautzky‐Willer, A. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01201-3 · Cited by 152
On the Colonic Bacterial Metabolism of Azo-Bonded Prodrugsof 5-Aminosalicylic Acid
Sousa, T., Yadav, V., Zann, V., Borde, A., Abrahamsson, B., & Basit, A. W. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24103 · Cited by 151
Self-citationLaksitorini, M. D., Prasasty, V. D., Kiptoo, P. K., & Siahaan, T. J. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.67 · Cited by 149
Abuhelwa, A. Y., Foster, D. J. R., & Upton, R. N. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9952-8 · Cited by 148
Koppel, N., Bisanz, J. E., Pandelia, M., Turnbaugh, P. J., & Balskus, E. P. (2018) · eLife · doi:10.7554/elife.33953 · Cited by 147
Keating, J. J., Bjarnason, I., Somasundaram, S. G., Macpherson, A. J., Francis, N., Price, A. B., Sharpstone, D. R., Smithson, J., Menzies, I. S., & Gazzard, B. (1995) · Gut · doi:10.1136/gut.37.5.623 · Cited by 145
Diakidou, A., Vertzoni, M., Goumas, K., Söderlind, E., Abrahamsson, B., Dressman, J., & Reppas, C. I. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9927-x · Cited by 144
Self-citationA critical review on tablet disintegration
Quodbach, J., & Kleinebudde, P. (2015) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2015.1045618 · Cited by 142
Gastrointestinal transit of non-disintegrating tablets in fed subjects
Khosla, R., Feely, L. C., & Davis, S. S. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90234-2 · Cited by 139
Weitschies, W., Blume, H. H., & Mönnikes, H. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.07.007 · Cited by 138
Self-citationPostprandial Changes in Solubilizing Capacity of Human Intestinal Fluids for BCS Class II Drugs
Clarysse, S., Psachoulias, D., Brouwers, J., Tack, J. F., Annaert, P., Duchateau, G. S. M. J. E., Reppas, C. I., & Augustijns, P. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9857-7 · Cited by 134
Self-citationGrimm, M. F., Koziolek, M., Kühn, J., & Weitschies, W. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.03.002 · Cited by 134
Self-citationSimrén, M., Törnblom, H., Palsson, O. S., Van Oudenhove, L., Whitehead, W. E., & Tack, J. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.019 · Cited by 131 · cited 1×
“care centres it has been demonstrated that about 20% of patients with chronic constipation present with slow transit (Camilleri et al., 2008; Simren et al., 2019).”
BackgroundEffect of pH and Comedication on Gastrointestinal Absorption of Posaconazole
Walravens, J., Brouwers, J., Spriet, I., Tack, J. F., Annaert, P., & Augustijns, P. (2011) · Clinical Pharmacokinetics · doi:10.2165/11592630-000000000-00000 · Cited by 131
Self-citationMechanisms of chylomicron uptake into lacteals
Dixon, J. B. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05716.x · Cited by 131
Knudsen, K., Fedorova, T. D., Bekker, A. C., Iversen, P., Østergaard, K., Krogh, K., & Borghammer, P. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-161050 · Cited by 131
Koziolek, M., Grimm, M. F., Garbacz, G., Kühn, J., & Weitschies, W. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500022u · Cited by 130
Self-citationCourcoulas, A. P., Coley, R. Y., Clark, J. M., McBride, C. L., Cirelli, E., McTigue, K. M., Arterburn, D. E., Coleman, K. J., Wellman, R., Anau, J., et al. (2020) · JAMA Surgery · doi:10.1001/jamasurg.2019.5470 · Cited by 129
Gastrointestinal and Nutritional Complications After Bariatric Surgery.
Decker, G. A., Swain, J. M., Crowell, M. D., & Scolapio, J. S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01421.x · Cited by 127
Precision Medicine Goes Microscopic: Engineering the Microbiome to Improve Drug Outcomes
Lam, K. N., Alexander, M., & Turnbaugh, P. J. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.06.011 · Cited by 126
Steroid absorption and enterohepatic recycling
Adlercreutz, H., Martin, F., Järvenpää, P., & Fotsis, T. (1979) · Contraception · doi:10.1016/0010-7824(79)90094-5 · Cited by 125
Disturbed gastric emptying in the short bowel syndrome. Evidence for a 'colonic brake'.
Nightingale, J. M., Kamm, M. A., van der Sijp, J. R., Morris, G. P., Walker, E. R. C., Mather, S. J., Britton, K. E., & Lennard‐Jones, J. E. (1993) · Gut · doi:10.1136/gut.34.9.1171 · Cited by 124
van Leeuwen, R. W. F., Peric, R., Hussaarts, K. G. A. M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.2560 · Cited by 121
Nakayama, H., Kinouchi, T., Kataoka, K., Akimoto, S., Matsuda, Y., & Ohnishi, Y. (1997) · Pharmacogenetics · doi:10.1097/00008571-199702000-00005 · Cited by 120
Association Between Proton Pump Inhibitor Use and Anemia: A Retrospective Cohort Study
Sarzynski, E. M., Puttarajappa, C. M., Xie, Y., Grover, M., & Laird-Fick, H. S. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1589-y · Cited by 120
Intravital imaging of intestinal lacteals unveils lipid drainage through contractility
Choe, K., Jang, J. Y., Park, I., Kim, Y.-S., Ahn, S., Park, D.-Y., Hong, Y., Alitalo, K. K., Koh, G. Y., & Kim, P. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76509 · Cited by 120
Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics
Thabet, Y., Klingmann, V., & Breitkreutz, J. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1138 · Cited by 120
Sunesen, V. H., Vedelsdal, R., Kristensen, H. G., Christrup, L. L., & Müllertz, A. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.11.005 · Cited by 119
Viramontes, B. E., Camilleri, M., McKinzie, S., Pardi, D. S., Burton, D. D., & Thomforde, G. M. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04138.x · Cited by 119
pH-Related Changes in the Absorption of Dipyridamole in the Elderly
Russell, T. L., Berardi, R. R., Barnett, J. L., O’Sullivan, T. L., Wagner, J. G., & Dressman, J. (1994) · Pharmaceutical Research · doi:10.1023/a:1018918316253 · Cited by 118
Fuchs, A., & Dressman, J. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24183 · Cited by 118
Supersaturation and Precipitation of Posaconazole Upon Entry in the Upper Small Intestine in Humans
Hens, B., Brouwers, J., Corsetti, M., & Augustijns, P. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24690 · Cited by 116
Self-citationEzzet, F., Krishna, G., Wexler, D. B., Statkevich, P., Kosoglou, T., & Batra, V. K. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80075-8 · Cited by 116
Vertzoni, M., Diakidou, A., Chatzilias, M., Söderlind, E., Abrahamsson, B., Dressman, J., & Reppas, C. I. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0223-6 · Cited by 116
Self-citationGender‐Specific Effects on Verapamil Pharmacokinetics and Pharmacodynamics in Humans
KRECICSHEPARD, M., Barnas, C., SLIMKO, J., Jones, M. P., & Schwartz, J. B. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022008883 · Cited by 116
Shackleford, D. M., Faassen, W. A., Houwing, N. S., Lass, H., Edwards, G. A., Porter, C. J. H., & Charman, W. N. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052522 · Cited by 113
Khoo, S., Edwards, G. A., Porter, C. J. H., & Charman, W. N. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1110 · Cited by 111
Pharmacokinetics of Drugs in Cachectic Patients: A Systematic Review
Trobec, K. Č., Kos, M. K., von Haehling, S., Springer, J., Anker, S. D., & Lainščak, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079603 · Cited by 111
Hens, B., Corsetti, M., Spiller, R. E., Marciani, L., Vanuytsel, T., Tack, J. F., Talattof, A., Amidon, G. L., Koziolek, M., Weitschies, W., et al. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.11.063 · Cited by 111
Self-citationCheeti, S., Budha, N. R., Rajan, S., Dresser, M. J., & Jin, J. Y. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1830 · Cited by 110
Basavaraj, S., & Betageri, G. V. (2014) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2013.12.003 · Cited by 110
Pedersen, P. B., Vilmann, P., Bar‐Shalom, D., Müllertz, A., & Baldursdóttir, S. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.05.007 · Cited by 109
Effect of Gastric Bypass Surgery on the Absorption and Bioavailability of Metformin
Padwal, R. S., Gabr, R. Q., Sharma, A. M., Langkaas, L.-A., Birch, D. W., Karmali, S., & Brocks, D. R. (2011) · Diabetes Care · doi:10.2337/dc10-2140 · Cited by 109
Inflammatory Markers in Anorexia Nervosa: An Exploratory Study
Dalton, B., Campbell, I. C., Chung, R., Breen, G. D., Schmidt, U. H., & Himmerich, H. (2018) · Nutrients · doi:10.3390/nu10111573 · Cited by 108
Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer
Chu, M. P., Hecht, J. R., Slamon, D. J., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3358 · Cited by 107
Age-mediated changes in the gastrointestinal tract
Merchant, H. A., Liu, F., Orlu, M., & Basit, A. W. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.024 · Cited by 106
Self-citationNicolas, J., Bouzom, F., Chanteux, H., & Ungell, A.-L. B. (2016) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2052 · Cited by 106
Kelly, K., O’Mahony, B., Lindsay, B., Jones, T., Grattan, T. J., Rostami‐Hodjegan, A., Stevens, H. N. E., & WILSON, C. G. (2003) · Pharmaceutical Research · doi:10.1023/a:1026155822121 · Cited by 105
Self-citationVarma, M. V. S., Lai, Y., Kimoto, E., Goosen, T. C., El‐Kattan, A. F., & Kumar, V. S. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0956-5 · Cited by 105
Kuno, T., Hirayama‐Kurogi, M., Ito, S., & Ohtsuki, S. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00259 · Cited by 105
Harnessing machine learning for development of microbiome therapeutics
McCoubrey, L. E., Elbadawi, M., Orlu, M., Gaisford, S., & Basit, A. W. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1872323 · Cited by 105
Self-citationGrimm, M. F., Scholz, E., Koziolek, M., Kühn, J., & Weitschies, W. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00623 · Cited by 104
Self-citationThe effects of pharmaceutical excipients on small intestinal transit.
Adkin, D. A., Davis, S. S., Sparrow, R., Huckle, P. D., Phillips, A., & Wilding, I. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04466.x · Cited by 102
Ontogeny of human pancreatic exocrine function.
McClean, P., & Weaver, L. T. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.68.1_spec_no.62 · Cited by 101
Microbiome and health implications for ethnic minorities after enforced lifestyle changes
Keohane, D. M., Ghosh, T. S., Jeffery, I. B., Molloy, M. G., O’Toole, P. W., & Shanahan, F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0963-8 · Cited by 101
Vita, R., Saraceno, G., Trimarchi, F., & Benvenga, S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2684 · Cited by 99
The transit of dosage forms through the small intestine
Yuen, K.-H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.045 · Cited by 98
Zawieja, S. D., Wang, W., Wu, X. Y., Nepiyushchikh, Z. V., Zawieja, D. C., & Muthuchamy, M. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00606.2011 · Cited by 96
Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism
Enright, E. F., Griffin, B. T., Gahan, C. G. M., & Joyce, S. A. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.04.009 · Cited by 96
Self-citationFasting gastric pH and its relationship to true hypochlorhydria in humans
Feldman, M. L., & Barnett, C. C. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01297133 · Cited by 92
Ashiru-Oredope, D. A. I., Patel, R., & Basit, A. W. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9635-y · Cited by 91
Self-citationNandhra, G. K., Mark, E. B., Tanna, G. L. D., Haase, A., Poulsen, J. L., Christodoulides, S., Kung, V., Klinge, M. W., Knudsen, K., Borghammer, P., et al. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13734 · Cited by 91
Sulfapyridine appearance in plasma after salicylazosulfapyridine
Kellow, J. E., Borody, T. J., Phillips, S. F., Haddad, A. C., & Brown, M. L. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90574-3 · Cited by 89
Pathophysiology and Treatment of Gastrointestinal Motility Disorders in the Acutely Ill
Deane, A. M., Chapman, M. J., Blaser, A. R., McClave, S. A., & Emmanuel, A. V. (2018) · Nutrition in Clinical Practice · doi:10.1002/ncp.10199 · Cited by 89
Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women
Bots, S. H., Groepenhoff, F., Eikendal, A. L. M., Tannenbaum, C., Rochon, P. A., Regitz‐Zagrosek, V., Miller, V. M., Day, D., Asselbergs, F. W., & den Ruijter, H. M. (2019) · JACC Heart Failure · doi:10.1016/j.jchf.2019.01.009 · Cited by 89
Ontogeny of oral drug absorption processes in children
Mooij, M. G., de Koning, B. A., Huijsman, M. L., & de Wildt, S. N. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.698261 · Cited by 88
Gut, oral and skin microbiome of Indian patrilineal families reveal perceptible association with age
Chaudhari, D. S., Dhotre, D. P., Agarwal, D. M., Gaike, A. H., Bhalerao, D., Jadhav, P., Mongad, D., Lubree, H., Sinkar, V. P., Patil, U. K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62195-5 · Cited by 88
Effect of Diet on the Development of Drug Metabolism by Cytochrome P-450 Enzymes in Healthy Infants
Blake, M. J., Abdel‐Rahman, S. M., Pearce, R. E., Leeder, J. S., & Kearns, G. L. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000245909.74166.00 · Cited by 87
Making Sense of Statistics in Clinical Trial Reports
Pocock, S., McMurray, J. J. V., & Collier, T. J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.014 · Cited by 86
Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?
Sharma, A., Buschmann, M. M., & Gilbert, J. A. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1437 · Cited by 86
Litou, C., Vertzoni, M., Goumas, C., Vasdekis, V., Xu, W., Kesisoglou, F., & Reppas, C. I. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1882-8 · Cited by 85
Self-citationGrimm, M. F., Koziolek, M., Saleh, M., Schneider, F., Garbacz, G., Kühn, J., & Weitschies, W. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00919 · Cited by 85
Self-citationKuo, B., Maneerattanaporn, M., Lee, A. A., Baker, J. R., Wiener, S. M., Chey, W. D., Wilding, G. E., & Hasler, W. L. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1751-6 · Cited by 84
Ghyselinck, J., Verstrepen, L., Moens, F., den Abbeele, P. V., Said, J., Smith, B., Bjarnason, I., Basit, A. W., & Gaisford, S. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119648 · Cited by 84
Self-citationWatts, P., Barrow, L., Steed, K., Wilson, C., Spiller, R., Melia, C. D., & Davies, M. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90245-w · Cited by 82
Self-citationLigand-mediated active targeting for enhanced oral absorption
Zhang, X., & Wu, W. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.001 · Cited by 82
Fritz, A., Busch, D., Łapczuk-Romańska, J., Ostrowski, M., Droździk, M., & Oswald, S. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13137 · Cited by 82
Basit, A. W., Newton, J. M., & Lacey, L. F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00018-2 · Cited by 81
Self-citationEnright, E. F., Joyce, S. A., Gahan, C. G. M., & Griffin, B. T. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01155 · Cited by 81
Self-citationRole of Physiological Intestinal Water in Oral Absorption
Sutton, S. C. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9087-2 · Cited by 80
Cvijić, S., Parojčić, J., & Langguth, P. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.04.008 · Cited by 80
Abuhelwa, A. Y., Foster, D. J. R., & Upton, R. N. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9953-7 · Cited by 80
Cited by
Advances in drug delivery systems, challenges and future directions
Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., Okoroafor, C. C., Eze, S. C., Kalu, O. L., Odoh, E. C., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17488 · Cited by 1,040
Evolution of drug delivery systems: From 1950 to 2020 and beyond
Park, H., Otte, A., & Park, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.030 · Cited by 475
Antibiotic perturbations to the gut microbiome
Fishbein, S. R. S., Mahmud, B., & Dantas, G. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00933-y · Cited by 440
“Additionally, depending on the chemical composition, formulation and administration route, antibiotics have different propensities to bioaccumulate in the gastrointestinal tract 73 ; this undoubtedly has a role in determining the magnitude of microbiome perturbation.”
BackgroundConnected healthcare: Improving patient care using digital health technologies
Awad, A., Trenfield, S. J., Pollard, T. D., Ong, J. J., Elbadawi, M., McCoubrey, L. E., Goyanes, A., Gaisford, S., & Basit, A. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113958 · Cited by 405
Self-citationThe Bioavailability of Drugs—The Current State of Knowledge
Stielow, M., Witczyńska, A., Kubryń, N., Fijałkowski, Ł., Nowaczyk, J., & Nowaczyk, A. (2023) · Molecules · doi:10.3390/molecules28248038 · Cited by 391
Metadata
- Authors
- Vinarov, Z., Abdallah, M., Agundez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., Ceulemans, J., Corsetti, M., Griffin, B. T., Grimm, M., Keszthelyi, D., Koziolek, M., Madla, C. M., Matthys, C., McCoubrey, L. E., Mitra, A., Reppas, C., Stappaerts, J., Steenackers, N., Trevaskis, N. L., Vanuytsel, T., Vertzoni, M., Weitschies, W., Wilson, C., & Augustijns, P.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 162
- Pages
- 105812
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W3138845742
- Cited by
- 359
- References
- 332
- FWCI
- 17.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.